We’re pleased to inform you that our Comprehensive Panel with Analyte Assurance™, along with the referenced panels below, will be updated for all orders effective September 29, 2025. The following analytes will be added: 5F-ADB Butanoic Acid Metabolite – Confirmed via...
We’re excited to share that our Comprehensive Panel with Analyte Assurance™, as well as the below referenced panels, have been updated in all orders effective June 2nd, 2025. The analytes that have been added are as follows: ortho-Methylfentanyl – Confirmed via...
Axis is pleased to recognize the four Forensic Medicine Fellows that recently completed Axis’ toxicology rotation. The rotation is a week-long virtual program where participants reviewed many aspects of a modern forensic toxicology operation, including the...
At this year’s MATT meeting, Dr. Laureen Marinetti spoke to attendees about how to differentiate between ketamine used illicitly versus ketamine used medically. She also discussed the origin of medical and illicit ketamine. Ketamine was developed in 1962 for use as...
At this year’s MATT meeting, Stuart Kurtz spoke to attendees about the prevalence of nitazene analogs and the concentrations at which Axis detects them. We have previously discussed what nitazenes are in blog posts (see links below). As a reminder, they are potent mu...
